Vilin Bio Med Share Price

Vilin Bio Med Limited was originally incorporated on June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad. The Company started its first commercial production in 2006. In 2007, the Company expanded the Phase 2 for Beta Lactum facility with 16000 sft for Tablet, Capsule and Dry Syrup sections. In 2010, it acquired more than 1000 molecules Drug Approvals with different strengths in therapeutics of Diabetic, Neuro and Cardio. The Company added the Sachet section in NonBeta Lactum facility in 2014. The Company allotted a fresh issue of 40,00,000 Equity Shares of Rs 10/ each by its Initial Public Offering by raising funds aggregating to Rs 12 Crore on June 7, 2023.At present, Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain competitiveness and to further the cause of Healthcare, Company has laid a RD Foundation and state of the art Manufacturing Facility in Roorkee. The major products for manufacturing dosage forms consist of Oral Liquid (Syrups/Suspensions/Dry Powders (eta Non etaLactam), Tablets Capsules (eta Non etaLactam) and External Preparations.Ointments along with similar products like Creams, Lotions, Gels or Pates are certain formulations primarily designed to be applied to the skin. BetaLactam are a group of medicines that are used to treat infections caused by some germs (bacteria and certain parasites). They do not work against infections that are caused by viruses for example, the common cold or flu. There are various type of dosages in this group like Tablets, Capsules, Injection and Dry Syrups for Oral Solution. NonBetaLactam Tablets Capsule Products group medicines are generally used for general diseases like Cold, Flu, Fever, Antigastrological, Antimalaria, and other viral diseases. Antibiotics are normally only prescribed for serious bacterial infections, as many infections get better independently.